Related content

ABCA7 and Pathogenic Pathways of Alzheimer’s Disease

By Aikawa Tomonori   Holm Marie-Louise   Kanekiyo Takahisa  

Brain Sciences, Vol. 8, Iss. 2, 2018-02 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?

By Murphy Kelsey E.   Park Joshua J.  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1168-1168

MDPI

Access to resources Recommend Favorite

MEG Connectivity Analysis in Patients with Alzheimer’s Disease Using Cross Mutual Information and Spectral Coherence

By Alonso Joan  

Annals of Biomedical Engineering, Vol. 39, Iss. 1, 2011-01 ,pp. : 524-536

Springer Publishing Company

Access to resources Recommend Favorite

Melatonin Therapy in Patients with Alzheimer’s Disease

By Cardinali Daniel P.   Vigo Daniel E.   Olivar Natividad   Vidal María F.   Brusco Luis I.  

Antioxidants, Vol. 3, Iss. 2, 2014-04 ,pp. : 245-277

MDPI

Access to resources Recommend Favorite

GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways

By Li Nan   Liu Bo-Wen   Ren Wen-Zhi   Liu Ju-Xiong   Li Su-Nan   Fu Shou-Peng   Zeng Ya-Long   Xu Shi-Yao   Yan Xuan   Gao Ying-Jie   Liu Dian-Feng   Wang Wei  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 190-190

MDPI

Access to resources Recommend Favorite